Brief: Lavipharm Q3 Sales Raises To EUR 9.13 Million
30/11/2020 17:25
Nov 30 (Reuters) - Lavipharm SA LPHr.AT :
* Q3 SALES AT EUR 9.13 MILLION VERSUS EUR 7.26 MILLION YEAR
AGO
* Q3 EBITDA AT EUR 1.35 MILLION VERSUS EUR 0.1 MILLION YEAR
AGO
Source text: https://bit.ly/33rlIEv
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY